Genzyme Cerezyme Medicare Outpatient Payment Set At 94% Of AWP
Executive Summary
Genzyme's Cerezyme and Ceredase will be reimbursed at 94% of average wholesale price under the final rule for 2004 reimbursement within the Medicare Hospital Outpatient Prospective Payment System
You may also be interested in...
Anti-Emetics Would Be Paid Separately Under Medicare Outpatient Rule
The chemotherapy-induced nausea treatments Anzemet, Kytril and Zofran would be reimbursed separately rather than bundled with a package of therapeutic services under the 2005 Medicare outpatient prospective payment system proposed rule
Anti-Emetics Would Be Paid Separately Under Medicare Outpatient Rule
The chemotherapy-induced nausea treatments Anzemet, Kytril and Zofran would be reimbursed separately rather than bundled with a package of therapeutic services under the 2005 Medicare outpatient prospective payment system proposed rule
“Functional Equivalence” For 2004: Aranesp OPPS Payment Is 78% Of AWP
Medicare will reimburse Amgen's Aranesp at about 78% of AWP under a revised Hospital Outpatient Prospective Payment System rule